CASE Op-Ed: Changes to Part D Move Country Closer to Government-Run Health Care
Matthew Kandrach – President, CASE February 26, 2018 – http://bit.ly/2BRIXLe The recently passed 600-page Bipartisan Budget Act of 2018 will impact...
CASE Op-Ed: Obamacare Hasn’t Helped Solve the Problem of Rehospitalization
Matthew Kandrach – President, CASE Feb 15, 2018, 7:00 AM – http://washex.am/2CmQ2jr Many Americans now pay more for their healthcare through increased out-of-pocket...
CASE Op-Ed: Idaho Health Plan Well Intentioned But Serves As Misguided Precedent
MATTHEW KANDRACH President, CASE February 12, 2018 – http://bit.ly/2o1kiuZ While health care has largely been eclipsed in national media, significant...
CASE Op-Ed: To improve health care, look to the free market, not a single-payer
Matt Kandrach – President, CASE February 9, 2018 – bit.ly/2EReVGH In today’s partisan environment, there is bipartisan agreement over one thing:...
ER Patients Get Rude Awakening from Health Insurance Policy Denying Coverage
The last thing anyone wants to do is visit the emergency room. But when Americans are facing a crisis, ERs...
CASE Op-Ed: Hospital Consolidation Is Driving Up Consumer Costs
Matthew Kandrach – President, CASE February 01, 2018 – http://bit.ly/2EullLQ The Affordable Care Act was the most radical restructuring of our...
CASE Op-Ed: Health care industry can learn something from airlines
The health care industry is shrinking. Mergers of hospitals, healthcare providers, insurers and pharmacy benefit managers has drastically changed the...
Survey: GOP Voters Want Obamacare and IPAB Gone, and for Congress to Act
Despite the GOP’s failed attempt earlier this year to repeal Obamacare, a new survey shows that dismantling any and all...
Are You Paying Too Much For Your Prescription? Maybe, But Your Pharmacist Isn’t Allowed To Tell You.
Pharmacy benefit managers (PBMs), which act as intermediaries between pharmaceutical manufacturers, insurers and pharmacies, operate behind the scenes and are...
CASE Op-Ed: Benefits of CVS/Aetna Merger Likely Elusive for Patients and Consumers
Gerard Scimeca, CASE Chairman December 11, 2017 – http://bit.ly/2AbxGBC With the recent $69 billion acquisition of Aetna insurance by CVS —...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/